AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2009
May 30, 2009
32801_dirs_2009-05-29_b8e9cc03-46f3-4dec-a02d-5dbe77bfa9ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2009-05-29
Reporting Person: DELEAGE JEAN (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-05-29 | Stock Option (Right to Buy) | $8.12 | A | 10000 | Acquired | 2019-05-29 | Common Stock (10000) | Direct |
Footnotes
F1: The shares vest monthly over twelve (12) months from the date of grant.
More from RIGEL PHARMACEUTICALS INC
Regulatory Filings
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19